The stock price performance for the year has been a mixed bag, indicating either a pessimistic or optimistic outlook depending on how you look at it. Year to date metric has recorded a loss of -56.26%.However, over the last six months, we can see a stronger performance of -68.84%. Over the last 30 days, the price of BHVN has leaped by -11.97%. And in the last five days, it has fallen by -19.32%.
Biohaven Ltd experienced a rather shaky stock market performance. The highest value in the past year was recorded at $55.70 on 10/08/24 and the lowest value was $15.79 on 05/15/25.
52-week price history of BHVN Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Biohaven Ltd’s current trading price is -70.67% away from its 52-week high, while its distance from the 52-week low is 3.47%. The stock’s price range during this period has varied between$15.79 and $55.70. The Biohaven Ltd’s shares, which operate in the Healthcare, saw a trading volume of around 2.31 million for the day, a figure considerably higher than their average daily volume of 1.62 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Biohaven Ltd (BHVN) has experienced a quarterly decline of -60.91% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.67B and boasts a workforce of 256 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 30.50, with a change in price of -19.57. Similarly, Biohaven Ltd recorded 1,386,231 in trading volume during the last 100 days, posting a change of -54.36%.
BHVN’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for BHVN stands at 0.14. Similarly, the long-term debt-to-equity ratio is also 0.12.
BHVN Stock Stochastic Average
Biohaven Ltd’s raw stochastic average for the past 50 days is presently 10.17%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 18.57%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 27.93% and 35.98%, respectively.
